Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-02

Clinical Trial Update: The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in Nigeria [NA]

View source ↗

Summary

This completed clinical trial assesses the impact of widescale sulfadoxine-pyrimethamine use on newborn outcomes in Nigeria, focusing on malaria-related outcome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: JSI Research & Training Institute, Inc. | Conditions: Malaria, Stillbirths | NA | Status: COMPLETED